Financial Daily from THE HINDU group of publications
Friday, Sep 23, 2005

Port Info

Group Sites

Corporate - Announcements

Glenmark files for Phase I trials in UK on diabetes drug

Our Bureau

Mumbai , Sept. 22

GLENMARK has filed to commence the first phase of human trials on its prospective diabetes drug molecule GRC 8200 in the UK.

Phase I of the study is expected to be completed in February 2006. Glenmark has also put in place an aggressive clinical development plan for GRC 8200 to reduce the gap with other competing molecules, also in early clinical trials.

In a release issued here today, the company said that its wholly owned subsidiary in Switzerland, Glenmark Pharmaceuticals S.A has filed for Phase I clinical trials for GRC 8200 with the Medicines and Healthcare Products Regulatory Agency [MHRA] in the UK.

The trials will be conducted by Parexel UK, a clinical research organisation, and it will be conducted using single and multiple oral doses on healthy volunteers. The objective of this study is to assess the safety and bio-availability of GRC 8200 in humans. For further development of the molecule, Glenmark plans to initiate a Proof of Concept (Phase IIA) study in South Africa in January 2006 on diabetic patients, along side with the Phase I trials.

Further, it has commenced various other non-clinical studies and expects to file an Investigational New Drug with the US FDA between April and June 2006 to commence Phase II, the note said.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Tata Safari Dicor

Stories in this Section
HOEC strikes oil in Gujarat

Sanmar Group co sells more stake in India Cements
Glenmark files for Phase I trials in UK on diabetes drug
Sterlite share allotment
Sakthi Sugars allocates Rs 25 cr for cane price equalisation fund
SQL Star to raise Rs 50 crore, restructure operations
SpiceJet to close $70-m FCCB issue in October
CLC bags Texprocil award for fabric export
Herbertsons board okays merger with McDowell
For better corporate governance — `Independent directors must serve on fewer boards'
Kudremukh to invest Rs 1,500 cr in expansion
Fuel woes may dampen NTPC's new projects
Strides, Jubilant among cos setting up new units in Karnataka
Tata Motors, Fiat tie up to explore cooperation in passenger car segment
HPCL, Maharashtra tie up for bio-diesel venture
Tata-Fiat alliance takes shape
DUBAL, L&T to set up Rs 15,000-cr refinery
Bravo, Tata!
Donation for school building
Jessop & Co plans 5:1 rights issue
Mallya unveils road map to form United Spirits
IOC will maintain profitability: Behuria
HPCL plans LNG terminal at Mundra — Eyeing stake in Hazira import terminal

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line